Muneaki Fujimoto - Japan Tobacco Executive Officer, Director of Medicine Business
| JAPAF Stock | USD 25.76 1.24 4.59% |
Director
Muneaki Fujimoto is Executive Officer, Director of Medicine Business of Japan Tobacco since 2012.
| Tenure | 12 years |
| Phone | 81 3 6636 2914 |
| Web | https://www.jt.com |
Japan Tobacco Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.12 %, meaning that it generated $0.12 on every $100 dollars invested by stockholders. Japan Tobacco's management efficiency ratios could be used to measure how well Japan Tobacco manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dessislava Temperley | Philip Morris International | 48 | |
| Peter Durman | Imperial Brands PLC | N/A | |
| Jennifer Li | Philip Morris International | 52 | |
| David OReilly | British American Tobacco | 58 | |
| Nabil Sakkab | Altria Group | 74 | |
| Hae Kim | British American Tobacco | 49 | |
| James Barrett | British American Tobacco | 49 | |
| Jack Bowles | British American Tobacco | 59 | |
| Frederik Paulsen | Philip Morris International | 70 | |
| Kalpana Morparia | Philip Morris International | 71 | |
| Tadeu Marroco | British American Tobacco | 58 | |
| Jerome Abelman | British American Tobacco | 60 | |
| Tadeu Marroco | British American Tobacco | 57 | |
| Peter Durman | Imperial Brands PLC | N/A | |
| Paul Lageweg | British American Tobacco | 54 | |
| Hae Kim | British American Tobacco | 50 | |
| Savio Kwan | British American Tobacco | 72 | |
| John Casteen | Altria Group | 77 | |
| Stephen Usher | Turning Point Brands | 54 | |
| Werner Geissler | Philip Morris International | 67 | |
| John Charnovich | Turning Point Brands | 63 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 |
Japan Tobacco Leadership Team
Elected by the shareholders, the Japan Tobacco's board of directors comprises two types of representatives: Japan Tobacco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Japan. The board's role is to monitor Japan Tobacco's management team and ensure that shareholders' interests are well served. Japan Tobacco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Japan Tobacco's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kazuhito Yamashita, Executive Officer | ||
| Masamichi Terabatake, President Executive President CEO, Representative Director | ||
| Nobuya Kato, VP CFO | ||
| Kiyohide Hirowatari, Chief Legal Officer and Sr. VP | ||
| Mutsuo Iwai, Senior Managing Executive Officer | ||
| Naohiro Minami, CFO and Sr. VP | ||
| Muneaki Fujimoto, Executive Officer, Director of Medicine Business | ||
| Osamu Hirose, Sr Counsel | ||
| Junichi Fukuchi, Executive Officer, Manager of Business Planning Office in Main Tobacco Business Unit | ||
| Dinesh Thotakura, Gen Division |
Japan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Japan Tobacco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 37.17 B | |||
| Shares Outstanding | 1.77 B | |||
| Shares Owned By Insiders | 34.36 % | |||
| Shares Owned By Institutions | 17.60 % | |||
| Price To Earning | 11.41 X | |||
| Price To Book | 1.36 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Japan Pink Sheet
Japan Tobacco financial ratios help investors to determine whether Japan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Japan with respect to the benefits of owning Japan Tobacco security.